{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:25:15Z","timestamp":1762521915257},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12883-016-0598-z","type":"journal-article","created":{"date-parts":[[2016,5,22]],"date-time":"2016-05-22T22:53:50Z","timestamp":1463957630000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Guillain-Barr\u00e9 syndrome following the 2009 pandemic monovalent and seasonal trivalent influenza vaccination campaigns in Spain from 2009 to 2011: outcomes from active surveillance by a neurologist network, and records from a country-wide hospital discharge database"],"prefix":"10.1186","volume":"16","author":[{"name":"Spanish GBS Epidemiology Study Group","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrique","family":"Alcalde-Cabero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Almaz\u00e1n-Isla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando J.","family":"Garc\u00eda L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Ram\u00f3n","family":"Ara-Callizo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuencisla","family":"Avellanal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Casasnovas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Cemill\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Ignacio","family":"Cuadrado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacinto","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Dolores","family":"Fern\u00e1ndez-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d3scar","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Antonio Garc\u00eda","family":"Merino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa Garc\u00eda","family":"Montero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dolores","family":"Montero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julio","family":"Pardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco Javier","family":"Rodr\u00edguez-Rivera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Ruiz-Tovar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas","family":"de Pedro-Cuesta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,5,21]]},"reference":[{"issue":"24","key":"598_CR1","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1056\/NEJMra1114525","volume":"366","author":"N Yuki","year":"2012","unstructured":"Yuki N, Hartung HP. Guillain-Barr\u00e9 syndrome. N Engl J Med. 2012;366(24):2294\u2013304.","journal-title":"N Engl J Med"},{"issue":"8","key":"598_CR2","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1191\/0269215505cr918oa","volume":"19","author":"A Forsberg","year":"2005","unstructured":"Forsberg A, Press R, Einarsson U, de Pedro-Cuesta J, Holmqvist LW. Disability and health-related quality of life in Guillain-Barr\u00e9 syndrome during the first two years after onset: a prospective study. Clin Rehabil. 2005;19(8):900\u20139.","journal-title":"Clin Rehabil"},{"issue":"26","key":"598_CR3","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJM198106253042601","volume":"304","author":"ES Hurwitz","year":"1981","unstructured":"Hurwitz ES, Schonberger LB, Nelson DB, Holman RC. Guillain-Barr\u00e9 syndrome and the 1978\u20131979 influenza vaccine. N Engl J Med. 1981;304(26):1557\u201361.","journal-title":"N Engl J Med"},{"issue":"9","key":"598_CR4","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1093\/oxfordjournals.aje.a115973","volume":"133","author":"TJ Safranek","year":"1991","unstructured":"Safranek TJ, Lawrence DN, Kurland LT, Culver DH, Wiederholt WC, Hayner NS, et al. Reassessment of the association between Guillain-Barr\u00e9 syndrome and receipt of swine influenza vaccine in 1976\u20131977: results of a two-state study. Expert Neurology Group. Am J Epidemiol. 1991;133(9):940\u201351.","journal-title":"Am J Epidemiol"},{"issue":"25","key":"598_CR5","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM199812173392501","volume":"339","author":"T Lasky","year":"1998","unstructured":"Lasky T, Terracciano GJ, Magder L, Koski CL, Ballesteros M, Nash D, et al. The Guillain-Barr\u00e9 syndrome and the 1992\u20131993 and 1993\u20131994 influenza vaccines. N Engl J Med. 1998;339(25):1797\u2013802.","journal-title":"N Engl J Med"},{"issue":"10","key":"598_CR6","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1002\/sim.2302","volume":"25","author":"HJ Whitaker","year":"2006","unstructured":"Whitaker HJ, Farrington CP, Spiessens B, Musonda P. Tutorial in biostatistics: the self-controlled case series method. Stat Med. 2006;25(10):1768\u201397.","journal-title":"Stat Med"},{"issue":"8","key":"598_CR7","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.jclinepi.2005.11.012","volume":"59","author":"JM Glanz","year":"2006","unstructured":"Glanz JM, McClure DL, Xu S, Hambidge SJ, Lee M, Kolczak MS, et al. Four different study designs to evaluate vaccine safety were equally validated with contrasting limitations. J Clin Epidemiol. 2006;59(8):808\u201318.","journal-title":"J Clin Epidemiol"},{"issue":"26","key":"598_CR8","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1016\/j.vaccine.2008.03.074","volume":"26","author":"DL McClure","year":"2008","unstructured":"McClure DL, Glanz JM, Xu S, Hambidge SJ, Mullooly JP, Baggs J. Comparison of epidemiologic methods for active surveillance of vaccine safety. Vaccine. 2008;26(26):3341\u20135.","journal-title":"Vaccine"},{"issue":"9876","key":"598_CR9","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/S0140-6736(12)62189-8","volume":"381","author":"DA Salmon","year":"2013","unstructured":"Salmon DA, Proschan M, Forshee R, Gargiullo P, Bleser W, Burwen DR, et al. Association between Guillain-Barr\u00e9 syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis. Lancet. 2013;381(9876):1461\u20138.","journal-title":"Lancet"},{"issue":"40","key":"598_CR10","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1016\/j.vaccine.2013.06.032","volume":"31","author":"CN Dodd","year":"2013","unstructured":"Dodd CN, Romio SA, Black S, Vellozzi C, Andrews N, Sturkenboom M, et al. International collaboration to assess the risk of Guillain Barr\u00e9 Syndrome following Influenza A (H1N1) 2009 monovalent vaccines. Vaccine. 2013;31(40):4448\u201358.","journal-title":"Vaccine"},{"issue":"31","key":"598_CR11","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1016\/j.vaccine.2015.05.013","volume":"33","author":"LH Mart\u00edn Arias","year":"2015","unstructured":"Mart\u00edn Arias LH, Sanz R, S\u00e1inz M, Trece\u00f1o C, Carvajal A. Guillain-Barr\u00e9 syndrome and influenza vaccines: a meta-analysis. Vaccine. 2015;33(31):3773\u20138.","journal-title":"Vaccine"},{"issue":"25","key":"598_CR12","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1056\/NEJMoa1006736","volume":"363","author":"J Wu","year":"2010","unstructured":"Wu J, Xu F, Lu L, Lu M, Miao L, Gao T, et al. Safety and effectiveness of a 2009 H1N1 vaccine in Beijing. N Engl J Med. 2010;363(25):2416\u201323.","journal-title":"N Engl J Med"},{"key":"598_CR13","doi-asserted-by":"crossref","first-page":"d5956","DOI":"10.1136\/bmj.d5956","volume":"343","author":"C Bardage","year":"2011","unstructured":"Bardage C, Persson I, Ortqvist A, Bergman U, Ludvigsson JF, Granath F. Neurological and autoimmune disorders after vaccination against pandemic influenza A (H1N1) with a monovalent adjuvanted vaccine: population based cohort study in Stockholm, Sweden. BMJ. 2011;343:d5956.","journal-title":"BMJ"},{"key":"598_CR14","doi-asserted-by":"crossref","unstructured":"Ghaderi S, Gunnes N, Bakken I, Magnus P, Trogstad L, H\u00e5berg SE. Risk of Guillain-Barr\u00e9 syndrome after exposure to pandemic influenza A(H1N1)pdm09 vaccination or infection: a Norwegian population-based cohort study. Eur J Epidemiol. 2016;31(1):67-72.","DOI":"10.1007\/s10654-015-0047-0"},{"issue":"15","key":"598_CR15","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/j.vaccine.2015.02.035","volume":"33","author":"C Kim","year":"2015","unstructured":"Kim C, Rhie S, Suh M, Kang DR, Choi YJ, Bae GR, et al. Pandemic influenza A vaccination and incidence of Guillain-Barr\u00e9 syndrome in Korea. Vaccine. 2015;33(15):1815\u201323.","journal-title":"Vaccine"},{"issue":"10","key":"598_CR16","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.2105\/AJPH.2011.300510","volume":"102","author":"DR Burwen","year":"2012","unstructured":"Burwen DR, Sandhu SK, MaCurdy TE, Kelman JA, Gibbs JM, Garcia B, et al. Surveillance for Guillain-Barr\u00e9 syndrome after influenza vaccination among the Medicare population, 2009\u20132010. Am J Public Health. 2012;102(10):1921\u20137.","journal-title":"Am J Public Health"},{"key":"598_CR17","doi-asserted-by":"crossref","unstructured":"Savulescu C, Jim\u00e9nez-Jorge S, de Mateo S, Ledesma J, Pozo F, Casas I, et al. Effectiveness of the 2010\/11 seasonal trivalent influenza vaccine in Spain: preliminary results of a case\u2013control study. Euro Surveill. 2011;16(11):pii:19820.","DOI":"10.2807\/ese.16.11.19820-en"},{"key":"598_CR18","doi-asserted-by":"crossref","unstructured":"Jim\u00e9nez-Jorge S, de Mateo S, Pozo F, Casas I, Garc\u00eda Cenoz M, Castilla J, et al. Early estimates of the effectiveness of the 2011\/12 influenza vaccine in the population targeted for vaccination in Spain, 25 December 2011 to 19 February 2012. Euro Surveill. 2012;17(12):pii:20129.","DOI":"10.2807\/ese.17.12.20129-en"},{"issue":"1","key":"598_CR19","doi-asserted-by":"crossref","first-page":"e1000388","DOI":"10.1371\/journal.pmed.1000388","volume":"8","author":"M Valenciano","year":"2011","unstructured":"Valenciano M, Kissling E, Cohen JM, Oroszi B, Barret AS, Rizzo C, et al. Estimates of pandemic influenza vaccine effectiveness in Europe, 2009\u20132010: results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) multicentre case\u2013control study. PLoS Med. 2011;8(1):e1000388.","journal-title":"PLoS Med"},{"key":"598_CR20","unstructured":"Ministerio de Sanidad y Consumo. Real Decreto 2210\/1995, de 28 diciembre, por el que se crea la red nacional de vigilancia epidemiol\u00f3gica. http:\/\/www.boe.es\/diario_boe\/txt.php?id=BOE-A-1996-1502 . Bolet\u00edn Oficial del Estado 24 enero 1996, n\u00fam. 21, 2153\u20132158. 28-12-1995. 1502. Accessed 3 Mar 2016."},{"issue":"2","key":"598_CR21","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000050769","volume":"46","author":"JL Cuadrado","year":"2001","unstructured":"Cuadrado JL, de Pedro-Cuesta J, Ara JR, Cemill\u00e1n CA, D\u00edaz M, Duarte J, et al. Guillain-Barr\u00e9 syndrome in Spain, 1985\u20131997: epidemiological and public health views. Eur Neurol. 2001;46(2):83\u201391.","journal-title":"Eur Neurol"},{"issue":"2","key":"598_CR22","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10072-004-0231-6","volume":"25","author":"JL Cuadrado","year":"2004","unstructured":"Cuadrado JL, de Pedro-Cuesta J, Ara JR, Cemill\u00e1n CA, D\u00edaz M, Duarte J, et al. Public health surveillance and incidence of adulthood Guillain-Barr\u00e9 syndrome in Spain, 1998\u20131999: the view from a sentinel network of neurologists. Neurol Sci. 2004;25(2):57\u201365.","journal-title":"Neurol Sci"},{"issue":"6","key":"598_CR23","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/ana.410030628","volume":"3","author":"AK Asbury","year":"1978","unstructured":"Asbury AK, Arnason BG, Karp HR, McFarlin DE. Criteria for diagnosis of Guillain-Barr\u00e9 syndrome. Ann Neurol. 1978;3(6):565\u20136.","journal-title":"Ann Neurol"},{"issue":"3","key":"598_CR24","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.vaccine.2010.06.003","volume":"29","author":"JJ Sejvar","year":"2011","unstructured":"Sejvar JJ, Kohl KS, Gidudu J, Amato A, Bakshi N, Baxter R, et al. Guillain-Barr\u00e9 syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine. 2011;29(3):599\u2013612.","journal-title":"Vaccine"},{"key":"598_CR25","unstructured":"Ministerio de Sanidad Servicios Sociales e Igualdad. Registro de Altas de los Hospitales Generales del Sistema Nacional de Salud. CMBD. Norma Estatal. www.msssi.gob.es . 2014. 25-2-2014. Accessed 3 Mar 2016."},{"issue":"2","key":"598_CR26","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/oxfordjournals.aje.a115507","volume":"131","author":"K Ulm","year":"1990","unstructured":"Ulm K. A simple method to calculate the confidence interval of a standardized mortality ratio (SMR). Am J Epidemiol. 1990;131(2):373\u20135.","journal-title":"Am J Epidemiol"},{"issue":"2","key":"598_CR27","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1034\/j.1600-0404.2000.101002104.x","volume":"101","author":"Q Cheng","year":"2000","unstructured":"Cheng Q, Jiang GX, Fredrikson S, Link H, de Pedro-Cuesta J. Epidemiological surveillance of Guillain-Barr\u00e9 syndrome in Sweden, 1996\u20131997. Network members of the Swedish GBS Epidemiology Study Group. Acta Neurol Scand. 2000;101(2):104\u201310.","journal-title":"Acta Neurol Scand"},{"issue":"16","key":"598_CR28","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1016\/j.vaccine.2013.02.009","volume":"31","author":"D Funch","year":"2013","unstructured":"Funch D, Holick C, Velentgas P, Clifford R, Wahl PM, McMahill-Walraven C, et al. Algorithms for identification of Guillain-Barr\u00e9 Syndrome among adolescents in claims databases. Vaccine. 2013;31(16):2075\u20139.","journal-title":"Vaccine"},{"issue":"3","key":"598_CR29","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/aje\/kwn310","volume":"169","author":"J Stowe","year":"2009","unstructured":"Stowe J, Andrews N, Wise L, Miller E. Investigation of the temporal association of Guillain-Barr\u00e9 syndrome with influenza vaccine and influenzalike illness using the United Kingdom General Practice Research Database. Am J Epidemiol. 2009;169(3):382\u20138.","journal-title":"Am J Epidemiol"},{"issue":"9","key":"598_CR30","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S1473-3099(13)70104-X","volume":"13","author":"JC Kwong","year":"2013","unstructured":"Kwong JC, Vasa PP, Campitelli MA, Hawken S, Wilson K, Rosella LC, et al. Risk of Guillain-Barr\u00e9 syndrome after seasonal influenza vaccination and influenza health-care encounters: a self-controlled study. Lancet Infect Dis. 2013;13(9):769\u201376.","journal-title":"Lancet Infect Dis"},{"issue":"17","key":"598_CR31","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1016\/j.vaccine.2015.02.064","volume":"33","author":"S Iqbal","year":"2015","unstructured":"Iqbal S, Li R, Gargiullo P, Vellozzi C. Relationship between Guillain-Barr\u00e9 syndrome, influenza-related hospitalizations, and influenza vaccine coverage. Vaccine. 2015;33(17):2045\u20139.","journal-title":"Vaccine"},{"issue":"2","key":"598_CR32","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1001\/jama.2012.7342","volume":"308","author":"P Wals de","year":"2012","unstructured":"de Wals P, Deceuninck G, Toth E, Boulianne N, Brunet D, Boucher RM, et al. Risk of Guillain-Barr\u00e9 syndrome following H1N1 influenza vaccination in Quebec. JAMA. 2012;308(2):175\u201381.","journal-title":"JAMA"},{"issue":"5","key":"598_CR33","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s10654-013-9797-8","volume":"28","author":"F Galeotti","year":"2013","unstructured":"Galeotti F, Massari M, D\u2019Alessandro R, Beghi E, Chio A, Logroscino G, et al. Risk of Guillain-Barr\u00e9 syndrome after 2010\u20132011 influenza vaccination. Eur J Epidemiol. 2013;28(5):433\u201344.","journal-title":"Eur J Epidemiol"},{"key":"598_CR34","doi-asserted-by":"crossref","first-page":"d3908","DOI":"10.1136\/bmj.d3908","volume":"343","author":"J Dieleman","year":"2011","unstructured":"Dieleman J, Romio S, Johansen K, Weibel D, Bonhoeffer J, Sturkenboom M. Guillain-Barr\u00e9 syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case\u2013control study in Europe. BMJ. 2011;343:d3908.","journal-title":"BMJ"},{"issue":"12","key":"598_CR35","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.3201\/eid1912.130643","volume":"19","author":"GP Giambrone","year":"2013","unstructured":"Giambrone GP, Zansky SM, Eidson M, Duncan PG, McNutt LA, Birkhead GS. Guillain-Barr\u00e9 syndrome surveillance during National Influenza Vaccination Campaign, New York, U.S.A., 2009. Emerg Infect Dis. 2013;19(12):1956\u201362.","journal-title":"Emerg Infect Dis"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-016-0598-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T17:04:10Z","timestamp":1656522250000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-016-0598-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,21]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["598"],"URL":"https:\/\/doi.org\/10.1186\/s12883-016-0598-z","relation":{},"ISSN":["1471-2377"],"issn-type":[{"type":"electronic","value":"1471-2377"}],"subject":[],"published":{"date-parts":[[2016,5,21]]},"article-number":"75"}}